Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Total 13F shares
-
7,807,573
-
Share change
-
+636,811
-
Total reported value
-
$149,921,645
-
Put/Call ratio
-
148%
-
Price per share
-
$19.19
-
Number of holders
-
75
-
Value change
-
+$11,782,962
-
Number of buys
-
29
-
Number of sells
-
32
Institutional Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q4 2014
As of 31 Dec 2014,
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,807,573 shares.
The largest 10 holders included
Birchview Capital, LP, VANGUARD GROUP INC, FIRST REPUBLIC INVESTMENT MANAGEMENT, INC., BlackRock Fund Advisors, Miura Global Management, LLC, State Street Corp, BlackRock Institutional Trust Company, N.A., OBERMEYER WOOD INVESTMENT COUNSEL, LLLP, NORTHERN TRUST CORP, and Selkirk Management LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.